Printer Friendly

BRISTOL-MYERS SQUIBB FORUM ON BIOSCIENCE INDUSTRY

 BRISTOL-MYERS SQUIBB FORM ON BIOSCIENCE INDUSTRY
+ A panel of leading government representatives and senior executives


from the bioscience industry will discuss issues facing this important growth industry in a forum at the Bristol-Myers Squibb Company, Route 206, Princeton, Wednesday, June 3.
 The forum is the inaugural gathering of the New Jersey Bioscience Association.
 A keynote speech will be delivered by Andrew G. Bodnar, M.D., J.D., Bristol-Myers Squibb Pharmaceutical Group's vice president of strategic management. He oversees licensing, commercial development and strategic product planning in various therapeutic areas. Bodnar is a cardiologist and an attorney, having received an A.B. from Harvard, an M.D. from Columbia University and a J.D. from Harvard Law School. His internship and residency at Massachusetts General Hospital coincided with research fellowships at Harvard Medical School and Massachusetts General Hospital.
 Members of the press are invited to attend. The forum begins promptly at 8:30 a.m. and will conclude at 10:45 a.m. Space is extremely limited. Please R.S.V.P. to Art Karacsony at (201) 829-9208.
 CONTACT: Jane Kramer of Bristol-Myers Squibb, 609-252-5185.
 -0- 6/1/92
 (BMY) CO: Bristol-Myers Squibb ST: New Jersey IN: MTC SU:


PS -- NY066 -- 5799 06/01/92 14:46 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 1, 1992
Words:207
Previous Article:ABB-DESIGNED GAS TURBINES ACHIEVE INTERNATIONAL SUCCESS
Next Article:INDUSTRIAL TRAINING SYSTEMS ANNOUNCES FIRST NINE MONTHS FINANCIAL RESULTS
Topics:


Related Articles
BRISTOL-MYERS SQUIBB ANNOUNCES AGREEMENT WITH SCHERING AG
BRISTOL-MYERS SQUIBB ANNOUNCES COURT RULING
IXSYS AND BRISTOL-MYERS SQUIBB ANNOUNCE RESEARCH AGREEMENT ON TUMOR-ASSOCIATED ANTIBODIES
Bristol-Myers Squibb is Honored for its Diversity Efforts by The Long Island Hispanic Business Community.
BIO CEO Panel to Address Faster, Lower Risk and Higher Return Approaches to Drug R&D at Annual BIO Industry CEO and Investor Conference; Companies...
Tripos to Integrate FormsBUILDER Technology Into Bristol-Myers Squibb's SMART-IDEA Application.
Tim Ravenscroft Named President, Bristol-Myers Squibb Medical Imaging.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters